Los Angeles Capital Management’s Immunovant IMVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-10,026
Closed -$265K 1224
2024
Q2
$265K Sell
10,026
-4,345
-30% -$115K ﹤0.01% 1055
2024
Q1
$464K Buy
14,371
+9,335
+185% +$302K ﹤0.01% 894
2023
Q4
$212K Buy
+5,036
New +$212K ﹤0.01% 1083
2021
Q2
Sell
-13,880
Closed -$223K 1604
2021
Q1
$223K Buy
+13,880
New +$223K ﹤0.01% 1513